Effect of dapagliflozin on outcomes in women and men with heart failure with reduced ejection fraction in the DAPA-HF trial

被引：0
|
作者：
Butt, J. H. [1 ]
Kober, L. [1 ]
Docherty, K. F. [2 ]
Inzucchi, S. E. [3 ]
Kosiborod, M. N. [4 ]
Langkilde, A. M. [5 ]
Martinez, F. [6 ]
Bengtsson, O. [5 ]
Ponikowski, P. [7 ]
Demets, D. L. [8 ]
Sjostrand, M. [5 ]
Sabatine, M. S. [9 ]
Solomon, S. D. [9 ]
Jhund, P. S. [2 ]
Mcmurray, J. John [2 ]
机构：
[1] Univ Copenhagen, Dept Cardiol, Copenhagen, Denmark
[2] Univ Glasgow, Glasgow, Lanark, Scotland
[3] Yale Univ, Sch Med, Dept Endocrinol, New Haven, CT USA
[4] St Lukes Mid Amer Heart Inst, Kansas City, MO USA
[5] AstraZeneca, Gothenburg, Sweden
[6] Univ Cordoba, Cordoba, Argentina
[7] Wroclaw Med Univ, Warsaw, Poland
[8] Univ Wisconsin, Madison, WI 53706 USA
[9] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA 02115 USA
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2020年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
90
引用
收藏
页码：9 / 10
页数：2
相关论文
共 50 条
  • [1] Effect of dapagliflozin on outcomes according to aetiology in patients with heart failure and reduced ejection fraction in the DAPA-HF trial
    Butt, J. H.
    Kober, L.
    Docherty, K. F.
    Inzucchi, S. E.
    Kosiborod, M. N.
    Langkilde, A. M.
    Martinez, F. A.
    Bengtsson, O.
    Ponikowski, P.
    Demets, D. L.
    Sjostrand, M.
    Sabatine, M. S.
    Solomon, S. D.
    Jhund, P. S.
    Mcmurray, J. John
    EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 : 10 - 10
  • [2] The Effect of Dapagliflozin on Anemia in Patients With Heart Failure and Reduced Ejection Fraction: An Analysis of DAPA-HF
    Docherty, Kieran
    Inzucchi, Silvio E.
    Kober, Lars
    Kosiborod, Mikhail
    Langkilde, Anna Maria
    Martinez, Feilpe
    Bengtsson, Olof
    Ponikowski, Piotr
    Sabatine, Marc S.
    Sjastrand, Mikaela
    Solomon, Scott
    Jhund, Pardeep S.
    McMurray, John J.
    CIRCULATION, 2020, 142
  • [3] Dapagliflozin and Diuretic Use in Patients With Heart Failure and Reduced Ejection Fraction in DAPA-HF
    Jackson, Alice M.
    Dewan, Pooja
    Anand, Inder S.
    Belohlavek, Jan
    Bengtsson, Olof
    de Boer, Rudolf A.
    Boehm, Michael
    Boulton, David W.
    Chopra, Vijay K.
    DeMets, David L.
    Docherty, Kieran F.
    Dukat, Andrej
    Greasley, Peter J.
    Howlett, Jonathan G.
    Inzucchi, Silvio E.
    Katova, Tzvetana
    Kober, Lars
    Kosiborod, Mikhail N.
    Langkilde, Anna Maria
    Lindholm, Daniel
    Ljungman, Charlotta E. A.
    Martinez, Felipe A.
    O'Meara, Eileen
    Sabatine, Marc S.
    Sjostrand, Mikaela
    Solomon, Scott D.
    Tereshchenko, Sergey
    Verma, Subodh
    Jhund, Pardeep S.
    McMurray, John J. V.
    CIRCULATION, 2020, 142 (11) : 1040 - 1054
  • [4] Dapagliflozin and Recurrent Heart Failure Hospitalizations in Heart Failure With Reduced Ejection Fraction An Analysis of DAPA-HF
    Jhund, Pardeep S.
    Ponikowski, Piotr
    Docherty, Kieran F.
    Gasparyan, Samvel B.
    Bohm, Michael
    Chiang, Chern-En
    Desai, Akshay S.
    Howlett, Jonathon
    Kitakaze, Masafumi
    Petrie, Mark C.
    Verma, Subodh
    Bengtsson, Olof
    Langkilde, Anna-Maria
    Sjostrand, Mikaela
    Inzucchi, Silvio E.
    Kober, Lars
    Kosiborod, Mikhail N.
    Martinez, Felipe A.
    Sabatine, Marc S.
    Solomon, Scott D.
    McMurray, John J., V
    CIRCULATION, 2021, 143 (20) : 1962 - 1972
  • [5] Dapagliflozin and atrial fibrillation in heart failure with reduced ejection fraction: insights from DAPA-HF
    Butt, Jawad H.
    Docherty, Kieran F.
    Jhund, Pardeep S.
    Boer, Rudolf A.
    Bohm, Michael
    Desai, Akshay S.
    Howlett, Jonathan G.
    Inzucchi, Silvio E.
    Kosiborod, Mikhail N.
    Martinez, Felipe A.
    Nicolau, Jose C.
    Petrie, Mark C.
    Ponikowski, Piotr
    Bengtsson, Olof
    Langkilde, Anna Maria
    Schou, Morten
    Sjostrand, Mikaela
    Solomon, Scott D.
    Sabatine, Marc S.
    McMurray, John J., V
    Kober, Lars
    EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 (03) : 513 - 525
  • [6] Influence of Ejection Fraction on the Effect of Treatment in the Dapagliflozin and Prevention of Adverse-Outcomes in Heart Failure Trial (DAPA-HF)
    Solomon, Scott
    DeMets, David L.
    Inzucchi, Silvio E.
    Kober, Lars
    Kosiborod, Mikhail N.
    Langkilde, Anna Maria
    Martinez, Felipe
    Bengtsson, Olof
    Ponikowski, Piotr
    Sabatine, Marc S.
    Sjostrand, Mikaela
    McMurray, John J.
    CIRCULATION, 2019, 140 (25) : E973 - E973
  • [7] Efficacy of Dapagliflozin on Renal Function and Outcomes in Patients With Heart Failure With Reduced Ejection Fraction Results of DAPA-HF
    Jhund, Pardeep S.
    Solomon, Scott D.
    Docherty, Kieran F.
    Heerspink, Hiddo J. L.
    Anand, Inder S.
    Bohm, Michael
    Chopra, Vijay
    de Boer, Rudolf A.
    Desai, Akshay S.
    Ge, Junbo
    Kitakaze, Masafumi
    Merkley, Bela
    O'Meara, Eileen
    Shou, Morten
    Tereshchenko, Sergey
    Verma, Subodh
    Vinh, Pham Nguyen
    Inzucchi, Silvio E.
    Kober, Lars
    Kosiborod, Mikhail N.
    Martinez, Felipe A.
    Ponikowski, Piotr
    Sabatine, Marc S.
    Bengtsson, Olof
    Langkilde, Anna Maria
    Sjostrand, Mikaela
    McMurray, John J., V
    CIRCULATION, 2021, 143 (04) : 298 - 309
  • [8] Effect of Dapagliflozin on Outpatient Worsening of Patients With Heart Failure and Reduced Ejection Fraction A Prespecified Analysis of DAPA-HF
    Docherty, Kieran F.
    Jhund, Pardeep S.
    Anand, Inder
    Bengtsson, Olof
    Bohm, Michael
    de Boer, Rudolf A.
    DeMets, David L.
    Desai, Akshay S.
    Drozdz, Jaroslaw
    Howlett, Jonathan
    Inzucchi, Silvio E.
    Johanson, Per
    Katova, Tzvetana
    Kober, Lars
    Kosiborod, Mikhail N.
    Langkilde, Anna Maria
    Lindholm, Daniel
    Martinez, Felipe A.
    Merkely, Bela
    Nicolau, Jose C.
    O'Meara, Eileen
    Ponikowski, Piotr
    Sabatine, Marc S.
    Sjostrand, Mikaela
    Solomon, Scott D.
    Tereshchenko, Sergey
    Verma, Subodh
    McMurray, John J. V.
    CIRCULATION, 2020, 142 (17) : 1623 - 1632
  • [9] Efficacy and safety of dapagliflozin according to aetiology in heart failure with reduced ejection fraction: insights from the DAPA-HF trial
    Butt, Jawad H.
    Nicolau, Jose C.
    Verma, Subodh
    Docherty, Kieran F.
    Petrie, Mark C.
    Inzucchi, Silvio E.
    Schou, Morten
    Kosiborod, Mikhail N.
    Langkilde, Anna Maria
    Martinez, Felipe A.
    Ponikowski, Piotr
    Sabatine, Marc S.
    Sjostrand, Mikaela
    Solomon, Scott D.
    Bengtsson, Olof
    Jhund, Pardeep S.
    McMurray, John J. V.
    Kober, Lars
    EUROPEAN JOURNAL OF HEART FAILURE, 2021, 23 (04) : 601 - 613
  • [10] Budget impact evaluation of the DAPA-HF trial: is dapagliflozin cost-saving for the treatment of heart failure with reduced ejection fraction?
    Qin, L.
    Darlington, O.
    Miller, R.
    Mellstrom, C.
    Mcewan, P.
    EUROPEAN JOURNAL OF HEART FAILURE, 2021, 23 : 305 - 305
12345